LGNRF.PK

New Power to Legend Capital Carbon Neutral Investment Portfolio: Ruicycle Raises Over RMB 300 Million from Series B

Retrieved on: 
Monday, August 8, 2022

Meanwhile, centering on the national carbon peaking and carbon neutrality policies, Ruicycle has achieved the traceability of carbon footprint and the quantification of carbon reduction, continuously making contributions to low-carbon development for the new energy industrial chain.

Key Points: 
  • Meanwhile, centering on the national carbon peaking and carbon neutrality policies, Ruicycle has achieved the traceability of carbon footprint and the quantification of carbon reduction, continuously making contributions to low-carbon development for the new energy industrial chain.
  • Rooted in China, Legend Capital participated in the rise of many world-leading companies by solid investment coverage and systematic post-investment value-add.
  • Legend Capital values long-term sustainable investment and incorporates ESG into its long-term development strategy.
  • As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative.

Led by Legend Capital, The Leading Intelligent Special Robot Company AKA Robotics Completes Series A Financing

Retrieved on: 
Thursday, July 28, 2022

HONG KONG, July 28, 2022 - (ACN Newswire) - Shenzhen AKA Robotics Technology Co., LTD. (hereinafter referred to as "AKA Robotics"), a leading intelligent special robot company, recently completed its Series A financing round, which was led by Legend Capital.

Key Points: 
  • HONG KONG, July 28, 2022 - (ACN Newswire) - Shenzhen AKA Robotics Technology Co., LTD. (hereinafter referred to as "AKA Robotics"), a leading intelligent special robot company, recently completed its Series A financing round, which was led by Legend Capital.
  • The founding team of AKA Robotics was formed by experts in the field of robotics, coming from Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences.
  • AKA Robotics has taken the lead in forming large-scale applications in ships and is a leading enterprise in special robots.
  • At the same time, Legend Capital will continue to support AKA Robotics in growing into a global and platform-based special robot company by providing more proactive value-added services."

Legend Capital Portfolio Company: The Global-Leading AI Medical Imaging Company Lunit Goes Public Successfully

Retrieved on: 
Thursday, July 21, 2022

Lunit SCOPE is an AI biomarker for immunotherapy, providing therapy response information that can critically affect treatment outcomes for cancer patients.

Key Points: 
  • Lunit SCOPE is an AI biomarker for immunotherapy, providing therapy response information that can critically affect treatment outcomes for cancer patients.
  • For the past 4 years, Lunit not only has produced world-leading AI medical solutions but also gained its commercial value achieving rapid topline growth.
  • Legend Capital has invested heavily in companies that integrate technology and the medical industry and has kept betting on AI medical sectors.
  • In addition to Lunit, Legend Capital has also invested in AI medical companies such as Xbiome, an AI microbiome drug development company; StoneWise, an AI drug R&D platform; Deepwise, an AI medical imaging company; BioMap, a biocomputing platform; Deep Informatics ++, an AI medical pathology diagnosis company; and Unimed, an AI brain diagnosis and treatment platform.

Co-led by Legend Capital, Huili Biotechnology Completes Series A Financing Round with Hundreds of Million RMB

Retrieved on: 
Thursday, July 7, 2022

HONG KONG, July 7, 2022 - (ACN Newswire) - Jiangsu Huili Biotechnology Co., Ltd ("Huili Bio"), a next-generation synthetic biology enzyme computational design platform, recently announced the completion of its Series A financing round with hundreds of million RMB.

Key Points: 
  • HONG KONG, July 7, 2022 - (ACN Newswire) - Jiangsu Huili Biotechnology Co., Ltd ("Huili Bio"), a next-generation synthetic biology enzyme computational design platform, recently announced the completion of its Series A financing round with hundreds of million RMB.
  • Founded in 2018, Huili Bio is dedicated to the computational design of enzyme components at the core of synthetic biological reactions.
  • Huili Bio's enzyme computational design platform is the first computational platform in China to realize the full-scenario design of enzymes.
  • Legend Capital has long focused on investment in the 'IT+' industry, and Huili Bio is a model of combining information technology and biotechnology (IT+BT).

Legend Capital Increases Carbon Neutrality Investments: Portfolio Company Talent New Energy Completes A++ Financing Round with Several Hundred Million RMB

Retrieved on: 
Thursday, June 16, 2022

HONG KONG, June 16, 2022 - (ACN Newswire) - Legend Capital's portfolio company Talent New Energy, a new Chinese powerhouse in the solid-state battery industry, recently announced the completion of its Series A++ financing round with several hundred million RMB.

Key Points: 
  • HONG KONG, June 16, 2022 - (ACN Newswire) - Legend Capital's portfolio company Talent New Energy, a new Chinese powerhouse in the solid-state battery industry, recently announced the completion of its Series A++ financing round with several hundred million RMB.
  • Legend Capital initially invested in Talent New Energy by joining the Pre-A financing round and continued to support the company's development by following up this Series A++ financing round.
  • Under the global background of carbon peaking and carbon neutrality, the wind power, photovoltaic and energy storage industry are also ushering in a golden era, gradually replacing the traditional fossil energy.
  • Under the goals of carbon peaking and carbon neutrality, Legend Capital's investments focus on energy system decarbonization, vehicle electrification/intelligence and synthetic biology.